Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs (CONTINUUM)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
C. R. Bard
ClinicalTrials.gov Identifier:
NCT00908947
First received: May 26, 2009
Last updated: September 6, 2016
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: July 2019
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)